$TNON
Tenon Medical, Inc.

2022 Q3 Form 10-Q Financial Statement

#000157587222000775 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $208.0K $135.0K $71.00K
YoY Change 196.72% 513.64%
Cost Of Revenue $302.0K $271.0K $275.0K
YoY Change 1553.89% 2911.11%
Gross Profit -$94.00K -$136.0K -$204.0K
YoY Change -281.33% -1146.15%
Gross Profit Margin -45.19% -100.74% -287.32%
Selling, General & Admin $2.371M $4.663M $1.313M
YoY Change 53.25% 235.71%
% of Gross Profit
Research & Development $797.0K $657.0K $562.0K
YoY Change 32.49% 177.22%
% of Gross Profit
Depreciation & Amortization $24.00K $19.00K $10.00K
YoY Change 4344.44%
% of Gross Profit
Operating Expenses $3.168M $5.320M $1.875M
YoY Change 47.44% 227.18%
Operating Profit -$3.262M -$5.456M -$2.079M
YoY Change 55.57% 238.25%
Interest Expense $72.00K -$53.00K -$273.0K
YoY Change -127.02% -27.51%
% of Operating Profit
Other Income/Expense, Net $91.00K -$32.00K -$1.000K
YoY Change -48.39%
Pretax Income -$3.171M -$5.488M -$2.353M
YoY Change 34.18% 192.52%
Income Tax
% Of Pretax Income
Net Earnings -$3.171M -$5.488M -$2.353M
YoY Change 35.47% 229.61%
Net Earnings / Revenue -1524.52% -4065.19% -3314.08%
Basic Earnings Per Share -$0.28 -$0.65 -$2.38
Diluted Earnings Per Share -$0.28 -$0.65 -$209.4K
COMMON SHARES
Basic Shares Outstanding 11.24M 8.422K 990.0
Diluted Shares Outstanding 11.24K 8.422K 990.0

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.53M $16.02M $4.677M
YoY Change 35.19% 131.69%
Cash & Equivalents $3.153M $7.875M $4.677M
Short-Term Investments $9.381M $8.141M $0.00
Other Short-Term Assets $177.0K $139.0K $82.00K
YoY Change 73.33% 96.72%
Inventory $810.0K $628.0K $602.0K
Prepaid Expenses $177.0K $139.0K
Receivables $144.0K $75.00K $64.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.67M $16.86M $5.425M
YoY Change 44.36% 140.15%
LONG-TERM ASSETS
Property, Plant & Equipment $294.0K $241.0K $1.251M
YoY Change -74.46% -79.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $51.00K $51.00K $469.0K
YoY Change -84.83% -79.5%
Total Long-Term Assets $1.272M $1.273M $1.720M
YoY Change -14.46% -11.1%
TOTAL ASSETS
Total Short-Term Assets $13.67M $16.86M $5.425M
Total Long-Term Assets $1.272M $1.273M $1.720M
Total Assets $14.94M $18.13M $7.145M
YoY Change 36.37% 114.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $422.0K $345.0K $425.0K
YoY Change 53.58% 2.11%
Accrued Expenses $603.0K $1.657M $1.197M
YoY Change -42.24% 98.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $13.78M
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $1.266M $2.236M $15.40M
YoY Change -91.36% -78.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $724.0K $782.0K $840.0K
YoY Change -23.54% -21.75%
Total Long-Term Liabilities $724.0K $782.0K $840.0K
YoY Change -23.54% -21.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.266M $2.236M $15.40M
Total Long-Term Liabilities $724.0K $782.0K $840.0K
Total Liabilities $1.990M $3.018M $16.24M
YoY Change -88.48% -76.81%
SHAREHOLDERS EQUITY
Retained Earnings -$31.59M -$28.42M
YoY Change
Common Stock $11.00K $11.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.95M $15.11M -$22.74M
YoY Change
Total Liabilities & Shareholders Equity $14.94M $18.13M $7.145M
YoY Change 36.37% 114.53%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.171M -$5.488M -$2.353M
YoY Change 35.47% 229.61%
Depreciation, Depletion And Amortization $24.00K $19.00K $10.00K
YoY Change 4344.44%
Cash From Operating Activities -$3.413M -$2.763M -$2.464M
YoY Change 141.97% 131.83%
INVESTING ACTIVITIES
Capital Expenditures -$77.00K -$41.00K -$128.0K
YoY Change 334.78%
Acquisitions
YoY Change
Other Investing Activities -$1.240M -$8.141M $4.404M
YoY Change -84.23%
Cash From Investing Activities -$1.317M -$8.182M $4.276M
YoY Change -83.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.77M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 14.19M -54.00K
YoY Change -100.0% 80.51%
NET CHANGE
Cash From Operating Activities -3.413M -2.763M -2.464M
Cash From Investing Activities -1.317M -8.182M 4.276M
Cash From Financing Activities 0.000 14.19M -54.00K
Net Change In Cash -4.730M 3.248M 1.758M
YoY Change -14.05% -51.31%
FREE CASH FLOW
Cash From Operating Activities -$3.413M -$2.763M -$2.464M
Capital Expenditures -$77.00K -$41.00K -$128.0K
Free Cash Flow -$3.336M -$2.722M -$2.336M
YoY Change 139.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Local Phone Number
LocalPhoneNumber
649-5760
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
TNON
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001560293
dei Entity Address Country
EntityAddressCountry
CA
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41364
dei Entity Registrant Name
EntityRegistrantName
TENON MEDICAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-5574718
dei Entity Address Address Line1
EntityAddressAddressLine1
104 Cooper Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Gatos
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95032
dei City Area Code
CityAreaCode
408
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11236801
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7875000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2917000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
8141000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
4404000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
75000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76000
CY2022Q2 us-gaap Inventory Net
InventoryNet
628000
CY2021Q4 us-gaap Inventory Net
InventoryNet
188000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
139000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
87000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
16858000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7672000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101000
CY2022Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
51000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
41000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
981000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1084000
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
0
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
374000
CY2022Q2 us-gaap Assets
Assets
18131000
CY2021Q4 us-gaap Assets
Assets
9272000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
345000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
478000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1657000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1088000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
202000
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
31000
CY2022Q2 tnon Convertible Notes Payable And Accrued Interest Net Of Debt Discount Current
ConvertibleNotesPayableAndAccruedInterestNetOfDebtDiscountCurrent
0
CY2021Q4 tnon Convertible Notes Payable And Accrued Interest Net Of Debt Discount Current
ConvertibleNotesPayableAndAccruedInterestNetOfDebtDiscountCurrent
12857000
CY2022Q2 tnon Debt Discount Related To Related Parties
DebtDiscountRelatedToRelatedParties
0
CY2021Q4 tnon Debt Discount Related To Related Parties
DebtDiscountRelatedToRelatedParties
2000
CY2022Q2 tnon Convertible Notes Payable And Accrued Interest Due To Related Parties Net Of Debt Discount Current
ConvertibleNotesPayableAndAccruedInterestDueToRelatedPartiesNetOfDebtDiscountCurrent
0
CY2021Q4 tnon Convertible Notes Payable And Accrued Interest Due To Related Parties Net Of Debt Discount Current
ConvertibleNotesPayableAndAccruedInterestDueToRelatedPartiesNetOfDebtDiscountCurrent
649000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2236000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15274000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
782000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
911000
CY2022Q2 us-gaap Liabilities
Liabilities
3018000
CY2021Q4 us-gaap Liabilities
Liabilities
16185000
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10487904
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11236801
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11236801
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
989954
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
989954
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
11000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43657000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
113000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28416000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20575000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-139000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
15113000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20552000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18131000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9272000
CY2022Q2 us-gaap Revenues
Revenues
135000
CY2021Q2 us-gaap Revenues
Revenues
22000
us-gaap Revenues
Revenues
206000
us-gaap Revenues
Revenues
37000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
271000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
9000
us-gaap Cost Of Revenue
CostOfRevenue
546000
us-gaap Cost Of Revenue
CostOfRevenue
20000
CY2022Q2 us-gaap Gross Profit
GrossProfit
-136000
CY2021Q2 us-gaap Gross Profit
GrossProfit
13000
us-gaap Gross Profit
GrossProfit
-340000
us-gaap Gross Profit
GrossProfit
17000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
657000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
237000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1219000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
324000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1943000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
913000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2219000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
917000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2720000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
476000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3757000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
578000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
5320000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1626000
us-gaap Operating Expenses
OperatingExpenses
7195000
us-gaap Operating Expenses
OperatingExpenses
1819000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5456000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1613000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7535000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1802000
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
35000
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Gain Loss On Investments
GainLossOnInvestments
36000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
88000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
62000
us-gaap Interest Expense Debt
InterestExpenseDebt
362000
us-gaap Interest Expense Debt
InterestExpenseDebt
73000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-62000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-306000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-5488000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1675000
us-gaap Profit Loss
ProfitLoss
-7841000
us-gaap Profit Loss
ProfitLoss
-1876000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5488000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1665000
us-gaap Net Income Loss
NetIncomeLoss
-7841000
us-gaap Net Income Loss
NetIncomeLoss
-1865000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.21
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8422
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8422
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
830
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
830
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4726
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4726
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
842
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
842
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-5488000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1675000
us-gaap Profit Loss
ProfitLoss
-7841000
us-gaap Profit Loss
ProfitLoss
-1876000
CY2022Q2 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
27000
CY2021Q2 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
0
us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
27000
us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
0
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-21000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5536000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1675000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7889000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1876000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-10000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-11000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5536000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1665000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7889000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1865000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22736000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
552000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13765000
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
13868000
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1561000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-48000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-5488000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
15113000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2906000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
380000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1675000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4140000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-20552000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
721000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13765000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
13868000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1561000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-48000
us-gaap Profit Loss
ProfitLoss
-7841000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
15113000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2709000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
380000
us-gaap Profit Loss
ProfitLoss
-1876000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4140000
us-gaap Profit Loss
ProfitLoss
-7841000
us-gaap Profit Loss
ProfitLoss
-1876000
us-gaap Paid In Kind Interest
PaidInKindInterest
362000
us-gaap Paid In Kind Interest
PaidInKindInterest
72000
us-gaap Share Based Compensation
ShareBasedCompensation
721000
us-gaap Share Based Compensation
ShareBasedCompensation
65000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1561000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
380000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
103000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
440000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
147000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-133000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
305000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
569000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-97000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-23000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5227000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1191000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4404000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8141000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
169000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3906000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14139000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
8130000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
131000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52000
tnon Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
0
tnon Payments For Deferred Offering Costs
PaymentsForDeferredOfferingCosts
85000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14139000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7862000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-48000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4958000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6667000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2917000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7875000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6912000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
1000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
tnon Common Stock Issued Upon Conversion Of Preferred Stock
CommonStockIssuedUponConversionOfPreferredStock
13639000
tnon Common Stock Issued Upon Conversion Of Preferred Stock
CommonStockIssuedUponConversionOfPreferredStock
0
tnon Common Stock Issued Upon Conversion Of Debt
CommonStockIssuedUponConversionOfDebt
13868000
tnon Common Stock Issued Upon Conversion Of Debt
CommonStockIssuedUponConversionOfDebt
0
tnon Right Of Use Assets Obtained In Exchange For Lease Liability
RightOfUseAssetsObtainedInExchangeForLeaseLiability
0
tnon Right Of Use Assets Obtained In Exchange For Lease Liability
RightOfUseAssetsObtainedInExchangeForLeaseLiability
1195000
tnon Conversion Of Trade Payable To Law Firm To Note Payable
ConversionOfTradePayableToLawFirmToNotePayable
0
tnon Conversion Of Trade Payable To Law Firm To Note Payable
ConversionOfTradePayableToLawFirmToNotePayable
556000
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13765000
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Use of estimates</div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates made by management include, but are not limited to, realization of deferred tax assets, accrued liabilities, obsolescence of inventory, stock-based compensation and the fair value of the Company’s common stock and preferred stock.</div></div>
tnon Percentage Of Valuation Allowance In Deferred Tax Assets
PercentageOfValuationAllowanceInDeferredTaxAssets
1
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1965924
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2834908
CY2021Q2 us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
0
us-gaap Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities
0
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
35000
us-gaap Gain Loss On Investments
GainLossOnInvestments
36000
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
272000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
103000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101000
CY2022Q2 us-gaap Depreciation
Depreciation
19000
CY2021Q2 us-gaap Depreciation
Depreciation
0
us-gaap Depreciation
Depreciation
29000
us-gaap Depreciation
Depreciation
0
CY2022Q2 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1441000
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
846000
CY2022Q2 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
20000
CY2021Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
14000
CY2022Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
196000
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
228000
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1657000
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1088000
CY2021Q2 tnon Lessee Operating Lease Expiration Month And Year
LesseeOperatingLeaseExpirationMonthAndYear
2026-06
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
981000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1084000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
202000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
782000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
911000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1016000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1016000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1113000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
144000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
293000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
301000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
310000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
144000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1192000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
176000
us-gaap Operating Lease Payments
OperatingLeasePayments
140000
us-gaap Operating Lease Payments
OperatingLeasePayments
23000
CY2022Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P4Y
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3937550
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10487904
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
130000000
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
85739
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
727394
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
727394
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.32
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
552000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
721000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
0
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
574000
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
574000

Files In Submission

Name View Source Status
0001575872-22-000775-index-headers.html Edgar Link pending
0001575872-22-000775-index.html Edgar Link pending
0001575872-22-000775.txt Edgar Link pending
0001575872-22-000775-xbrl.zip Edgar Link pending
cm147_ex31-1.htm Edgar Link pending
cm147_ex31-2.htm Edgar Link pending
cm147_ex32-1.htm Edgar Link pending
cm147_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tnon-20220630_cal.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tnon-20220630.htm Edgar Link pending
tnon-20220630.xsd Edgar Link pending
tnon-20220630_def.xml Edgar Link unprocessable
tnon-20220630_lab.xml Edgar Link unprocessable
tnon-20220630_pre.xml Edgar Link unprocessable
tnon-20220630_htm.xml Edgar Link completed